Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%
No Thumbnail Available
Identifiers
Date
2018-10-01
Authors
Spira, A.
Planchard, D.
Cho, B. C.
Ozguroglu, M.
Daniel, D.
Villegas, A.
Vicente, D.
Hui, R.
Murakami, S.
Paz-Ares, L.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
durvalumab, PACIFIC, PD-L1